Filing Flows › Avita Medical (RCEL) › Q2 2026
Avita Medical (RCEL) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 6, 2026
Avita Medical (RCEL) reported revenue of $21.7M for the second quarter 2026 (Q2 2026), +18% from a year earlier and +13% from the quarter before. Operating margin was -31.6%, net loss $7.7M (35.3% of revenue).
Avita Medical, Q2 2026: revenue $21.7M (+18% year over year), operating margin -31.6%, net loss $7.7M, operating cash flow −$3.5M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $21.7M | +13% | +18% |
| Operating profit | −$6.9M | — | — |
| Net earnings | −$7.7M | — | — |
| Operating cash flow | −$3.5M | — | — |
What changed
Revenue was $21.7M in Q2 2026, up 18% year over year and up 13% from the previous quarter.
Gross margin was 81.9%, up 0.7 points from a year earlier. Operating costs exceeded revenue by $6.9M, an operating margin of -31.6%. Operating expenses fell 6% while revenue rose 18%. The quarter ended with a net loss of $7.7M, narrower than the previous quarter's $10.6M loss.
Operating cash flow was −$3.5M. Non-cash charges added back $605K of depreciation and amortization and $2.0M of share-based compensation. Working capital and other items added $1.6M. Capital expenditures of $108K exceeded it, leaving free cash flow of −$3.6M.
Questions
What was Avita Medical's revenue in the second quarter 2026?
Avita Medical (RCEL) reported revenue of $21.7M for the second quarter 2026 (Q2 2026), +18% from a year earlier and +13% from the quarter before.
Was Avita Medical profitable in the second quarter 2026?
Operating loss was $6.9M (-31.6% of revenue) and net loss $7.7M.
Source: Avita Medical 10-Q on SEC EDGAR.